September 2014

New Product - Rixubis

Rixubis (nonacog gamma (rch)) contains recombinant human factor IX synthesised by a genetically engineered Chinese hamster ovary (CHO) cell line. Rixubis is indicated for the routine prophylaxis of bleeding episodes in adults with haemophilia B; treatment and prevention of bleeding episodes in adults with haemophilia B (congenital factor IX deficiency) and peri-operative management in adults with haemophilia B. Rixubis is contraindicated in those with hypersensitivity to hamster protein. Rixubis is available as a powder for infusion (250 IU, 500 IU, 1000 IU, 2000 IU, 3000 IU) in a single use glass vial, in packs of 1’s..

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au